Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GCLLSG 2016

The German CLL Study Group
16–18 September 2016 | Cologne, Germany

GCLLSG 2016

The German CLL Study Group
16–18 September 2016 | Cologne, Germany
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs? 2:24
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
John Gribben • 17 Sep 2016
How to overcome resistance to new compounds in CLL 2:41
How to overcome resistance to new compounds in CLL
Arnon Kater • 17 Sep 2016
Highlights from the International Workshop of the German CLL Study Group 3:11
Highlights from the International Workshop of the German CLL Study Group
Michael Hallek • 17 Sep 2016
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL 1:11
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Stephan Stilgenbauer • 17 Sep 2016
How combining an evolutionary perspective with genomic methods can advance CLL treatment 4:54
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau • 17 Sep 2016
How to treat a previously untreated CLL patient 2:51
How to treat a previously untreated CLL patient
Barbara Eichhorst • 17 Sep 2016
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting 1:25
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting
Barbara Eichhorst • 16 Sep 2016
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek 1:33
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
Michael Hallek • 16 Sep 2016
The discovery and role of BCL2 and microRNA in CLL 4:04
The discovery and role of BCL2 and microRNA in CLL
Carlo Croce • 16 Sep 2016
Changes in research to overcome the problem of resistance to new CLL drugs 1:10
Changes in research to overcome the problem of resistance to new CLL drugs
Arnon Kater • 16 Sep 2016
The importance of the life cycle of CLL cells and how it can inform treatment 3:28
The importance of the life cycle of CLL cells and how it can inform treatment
Nicholas Chiorazzi • 16 Sep 2016
How to treat a previously treated CLL patient 2:16
How to treat a previously treated CLL patient
Carsten Niemann • 16 Sep 2016
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment 2:31
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment
Carsten Niemann • 16 Sep 2016
How the removal of macrophages from tissue can stop or slow down the progression of CLL 4:30
How the removal of macrophages from tissue can stop or slow down the progression of CLL
Federico Caligaris-Cappio • 16 Sep 2016
Information on the iwCLL 2017 meeting 1:06
Information on the iwCLL 2017 meeting
Stephan Stilgenbauer • 16 Sep 2016
Targeting ROR1 and a two-drug approach to cure CLL 5:30
Targeting ROR1 and a two-drug approach to cure CLL
Carlo Croce • 16 Sep 2016
The content of VJHemOnc is intended for healthcare professionals